In the general population, cytomegalovirus (CMV) is a common infection that is frequently
acquired at a young age; one in three children in the United States are infected with CMV. In …

The past 1–2 years have seen major developments in the area of CMV management in
transplant recipients. Expanding diagnostic and therapeutic capabilities provide a …

Cytomegalovirus (CMV) is among the most common of infections after transplant. In addition
to causing viral infection, it increases the risk for a negative outcome for the organ or bone …

Cytomegalovirus (CMV) continues to be a clinical problem, impairing the overall success
rate of transplantation, either through direct involvement of a variety of end‐organs or by …

Cytomegalovirus (CMV) infection is a major cause of morbidity and mortality after
hematopoietic stem cell transplantation. Significant progress has been made in the …

Cytomegalovirus (CMV) infection is one of the major infectious complications of organ
transplantation and contributes significantly to posttransplant morbidity and mortality. 51. 69 …

Cytomegalovirus (CMV) is one of the most common opportunistic infections that affect the
outcome of solid organ transplantation. This updated guideline from the American Society of …

Cytomegalovirus (CMV) continues to be responsible for a substantial fraction of the
morbidity and mortality that follows organ transplantation. The three major consequences of …

Despite the refinements in molecular methods for the detection of cytomegalovirus (CMV)
and the advent of highly effective preemptive strategies, CMV remains a leading cause of …

This chapter contains sections titled: Prevention of cytomegalovirus (CMV) disease in solid
organ transplant (SOT) recipients Interpretation of pediatric CMV serology in donors and …